Imunon, Inc.IMNNNASDAQ

Revenue (LTM)

Net Income (LTM)

$-19M

+4.6% YoY

Free Cash Flow

$-19M

Revenue CAGR (5Y)

—

—Marginsstable

FCF($0.0B)

Unprofitable

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Revenue	1	1↓0.0%	1↓0.0%	0	0
Gross Profit	1	1↓0.0%	1↓0.0%	0	0
Operating Income	-18	-21↓13.6%	-25↓18.6%	-21↑15.6%	-19↑9.0%
Net Income	-21	-21↑3.3%	-36↓72.8%	-20↑45.6%	-19↑4.6%
EBITDA	-21	-21↑2.0%	-32↓51.8%	-20↑37.3%	-18↑9.9%
EPS Diluted	-131.51	-748.77↓469.4%	-65.55↑91.2%	-28.14↑57.1%	-21.10↑25.0%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Cash & Equivalents	17	20↑14.1%	11↓41.3%	6↓49.2%	6↑0.6%
Total Current Assets	19	52↑175.9%	37↓29.2%	18↓50.4%	8↓56.1%
Total Assets	38	74↑97.3%	44↓40.6%	22↓50.2%	10↓55.7%
Total Current Liabilities	7	7↑0.2%	10↑48.3%	7↓26.4%	5↓35.2%
Total Liabilities	19	18↓3.5%	15↓19.7%	9↓41.8%	5↓35.8%
Total Equity	19	56↑199.8%	29↓47.4%	13↓54.4%	4↓68.3%
Total Debt	6	7↑7.1%	6↓5.5%	2↓74.1%	1↓29.9%
Net Debt	-11	-13↓18.1%	-5↑59.6%	-4↑19.4%	-5↓12.3%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Operating Cash Flow	-16	-16↓3.9%	-23↓42.4%	-19↑17.6%	-19↑0.9%
Capital Expenditure	-0	-0↓1532.2%	-0↑14.1%	-0↓68.7%	-0↑93.5%
Free Cash Flow	-16	-17↓5.7%	-23↓41.3%	-19↑16.7%	-19↑3.0%
Stock-Based Comp	2	4↑103.1%	3↓28.9%	1↓71.6%	0↓37.1%
Net Change in Cash	10	8↓18.1%	-8↓196.1%	-12↓44.0%	0↑100.3%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance